TREATMENTS &
RESEARCH

Search the
latest
treatment
information
here.

Dr. Huntley's
Diagnosis
Checklist

Have a symptom?
See what questions
a doctor would ask.
 
Diseases » Cancer » Diagnosis
 

Diagnosis of Cancer

Diagnostic Test list for Cancer:

The list of medical tests mentioned in various sources as used in the diagnosis of Cancer includes:

Cancer Diagnosis: Book Excerpts

Tests and diagnosis discussion for Cancer:

Cancer: NWHIC (Excerpt)

A biopsy is the only sure way to know whether a medical problem is cancer. In a biopsy, the doctor removes a sample of tissue. The tissue is examined under a microscope to check for cancer cells. (Source: excerpt from Cancer: NWHIC)

What You Need To Know About Cancer - An Overview: NCI (Excerpt)

In routine physical exams, the doctor looks for anything unusual and feels for any lumps or growths. Specific screening tests, such as lab tests, x-rays, or other procedures, are used routinely for only a few types of cancer.

  • Breast. A screening mammogram is the best tool available to find breast cancer before symptoms appear. A mammogram is a special kind of x-ray image of the breasts. Breast cancer screening has been shown to reduce the risk of dying from this disease. The National Cancer Institute recommends that women in their forties and older have mammograms on a regular basis, every 1 to 2 years.

  • Cervix. Doctors use the Pap test , or Pap smear, to screen for cancer of the cervix. For this test, cells are collected from the cervix. The cells are examined under a microscope to detect cancer or changes that may lead to cancer.

  • Colon and rectum. A number of screening tests are used to find colon and rectal (colorectal) cancer. If a person is over the age of 50 years, has a family medical history of colorectal cancer, or has any other risk factors for colorectal cancer, a doctor may suggest one or more of these tests.

    Sometimes tumors in the colon or rectum can bleed. The fecal occult blood test checks for small amounts of blood in the stool.

    The doctor sometimes uses a thin, lighted tube called a sigmoidoscope to examine the rectum and lower colon. Or, to examine the entire colon and rectum, a lighted instrument called a colonoscope is used. If abnormal areas are seen, tissue can be removed and examined under a microscope.

    A barium enema is a series of x-rays of the colon and rectum. The patient is given an enema with a solution that contains barium, which outlines the colon and rectum on the x-rays.

    A digital rectal exam is an exam in which the doctor inserts a lubricated, gloved finger into the rectum to feel for abnormal areas.

Although it is not certain that screening for other cancers actually saves lives, doctors also may suggest screening for cancers of the skin, lung, and oral cavity. And doctors may offer to screen men for prostate or testicular cancer, and women for ovarian cancer.

Doctors consider many factors before recommending a screening test. They weigh factors related to the individual, the test, and the cancer that the test is intended to detect. For example, doctors take into account the person's age, medical history and general health, family history, and lifestyle. The doctor pays special attention to a person's risk for developing specific types of cancer. In addition, the doctor will assess the accuracy and the risks of the screening test and any followup tests that may be necessary. Doctors also consider the effectiveness and side effects of the treatment that will be needed if cancer is found.

People may want to discuss any concerns or questions they have about screening with their doctors, so they can weigh the pros and cons and make informed decisions about having screening tests. (Source: excerpt from What You Need To Know About Cancer - An Overview: NCI)

What You Need To Know About Cancer - An Overview: NCI (Excerpt)

If symptoms are present, the doctor asks about the person's medical history and performs a physical exam. In addition to checking general signs of health, the doctor may order various tests and exams. These may include laboratory tests and imaging procedures. A biopsy is usually necessary to determine whether cancer is present.

Laboratory Tests

Blood and urine tests can give the doctor important information about a person's health. In some cases, special tests are used to measure the amount of certain substances, called tumor markers, in the blood, urine, or certain tissues. Tumor marker levels may be abnormal if certain types of cancer are present. However, lab tests alone cannot be used to diagnose cancer.

Imaging

Images (pictures) of areas inside the body help the doctor see whether a tumor is present. These pictures can be made in several ways.

X-rays are the most common way to view organs and bones inside the body. A computed tomography (CT or CAT) scan is a special kind of imaging that uses a computer linked to an x-ray machine to make a series of pictures.

In radionuclide scanning , the patient swallows or receives an injection of a radioactive substance. A machine (scanner) measures radioactivity levels in certain organs and prints a picture on paper or film. The doctor can detect abnormal areas by looking at the amount of radioactivity in the organs. The radioactive substance is quickly eliminated by the patient's body after the test is done.

Ultrasonography is another procedure for viewing areas inside the body. High-frequency sound waves that cannot be heard by humans enter the body and bounce back. Their echoes produce a picture called a sonogram . These pictures are shown on a monitor like a TV screen and can be printed on paper.

In MRI , a powerful magnet linked to a computer is used to make detailed pictures of areas in the body. These pictures are viewed on a monitor and can also be printed.

Biopsy

A biopsy is almost always necessary to help the doctor make a diagnosis of cancer. In a biopsy, tissue is removed for examination under a microscope by a pathologist . Tissue may be removed in three ways: endoscopy , needle biopsy, or surgical biopsy.

  • During an endoscopy, the doctor can look at areas inside the body through a thin, lighted tube. Endoscopy allows the doctor to see what's going on inside the body, take pictures, and remove tissue or cells for examination, if necessary.

  • In a needle biopsy, the doctor takes a small tissue sample by inserting a needle into the abnormal (suspicious) area.

  • A surgical biopsy may be excisional or incisional . In an excisional biopsy, the surgeon removes the entire tumor, often with some surrounding normal tissue. In an incisional biopsy, the doctor removes just a portion of the tumor. If cancer is present, the entire tumor may be removed immediately or during another operation.

Patients sometimes worry that having a biopsy (or any other type of surgery for cancer) will spread the disease. This is a very rare occurrence. Surgeons use special techniques and take many precautions to prevent cancer from spreading during surgery. For example, if tissue samples must be removed from more than one site, they use different instruments for each one. Also, a margin of normal tissue is often removed along with the tumor. Such efforts reduce the chance that cancer cells will spread into healthy tissue.

Some people may be concerned that exposing cancer to air during surgery will cause the disease to spread. This is not true. Exposure to air does not cause the cancer to spread.

Patients should discuss their concerns about the biopsy or other surgery with their doctor.

Staging

When cancer is diagnosed, the doctor will want to learn the stage , or extent, of the disease. Staging is a careful attempt to find out whether the cancer has spread and, if so, to which parts of the body. Treatment decisions depend on the results of staging. The doctor may order more laboratory tests and imaging studies or additional biopsies to find out whether the cancer has spread. An operation called a laparotomy can help the doctor find out whether cancer has spread within the abdomen. During this operation, a surgeon makes an incision into the abdomen and removes samples of tissue. (Source: excerpt from What You Need To Know About Cancer - An Overview: NCI)

Diagnosis of Cancer: medical news summaries:

The following medical news items are relevant to diagnosis and misdiagnosis issues for Cancer:

Diagnostic Tests for Cancer: Online Medical Books

16 MEDICAL BOOKS ONLINE! Review excerpts from medical books online, free, without registration, for more information about diagnostis of Cancer.


Breast cancer: Diagnosis
(Professional Guide to Diseases (Eighth Edition))

The most reliable method of detecting breast cancer is the clinical breast examination, followed by immediate evaluation of any abnormality. Other diagnostic measures include mammography, ultrasound, needle biopsy, and surgical biopsy. Mammography is indicated for any woman whose physical examination suggests breast cancer. It should be done as a baseline on women between ages 35 and 39 and annually on all women older than age 40, on those who have a family history of breast cancer, and on those who have had unilateral breast cancer (to check for new disease).

ELDER TIP Unfortunately, many older women don't receive regular mammograms, even when recommended by health care professionals, either because they fear radiation, discovering cancer, or discomfort during the procedure or because they're embarrassed about exposing their breasts.

The value of mammography is questionable for women under age 35 (because of the density of the breasts), except for those women who are strongly suspected of having breast cancer. False-negative results can occur in as many as 30% of all tests. Consequently, with a suspicious mass, a negative mammogram should be disregarded, and a fine-needle aspiration or surgical biopsy should be done. Ultrasonography, which can distinguish a fluid-filled cyst from a tumor, can also be used instead of an invasive surgical biopsy.

Bone scan, brain scan, computed tomography scan, measurement of alkaline phosphatase levels, liver function studies, and liver biopsy can detect distant metastases. A hormonal receptor assay done on the tumor can determine if the tumor is estrogen or progesterone dependent. (This test guides decisions to use therapy that blocks the action of the estrogen hormone that supports tumor growth.)

» READ BOOK EXCERPT ONLINE »

Source: Professional Guide to Diseases (Eighth Edition), 2005

Introduction: Malignant Neoplasms: Diagnostic methods
(Professional Guide to Diseases (Eighth Edition))

A thorough medical history and physical examination should precede sophisticated diagnostic procedures. Useful tests for the early detection and staging of tumors include X-ray, endoscopy, isotope scan, computed tomography scan, and magnetic resonance imaging, but the single most important diagnostic tool is a biopsy for direct histologic study of tumor tissue. Biopsy tissue samples can be taken by curettage, fluid aspiration (pleural effusion), fine-needle aspiration biopsy (breast), dermal punch (skin or mouth), endoscopy (rectal polyps), and surgical excision (visceral tumors and nodes).

An important tumor marker, carcinoembryonic antigen (CEA), although not diagnostic by itself, can signal malignancies of the large bowel, stomach, pancreas, lungs, and breasts. CEA titers range from normal (less than 5 ng) to suspicious (5 to 10 ng) to suspect (over 10 ng). CEA serves many valuable purposes:

❑as a baseline during chemotherapy to evaluate the extent of tumor spread

❑to regulate drug dosage

❑to prognosticate after surgery or radiation

❑to detect tumor recurrence.

Although no more specific than CEA, alpha-fetoproteina fetal antigen uncommon in adultscan suggest testicular, ovarian, gastric, and hepatocellular cancers. Beta human chorionic gonadotropin may point to testicular cancer or choriocarcinoma. Other commonly used tumor markers include prostate-specific antigen to detect and monitor prostatic cancer, and CA-125, useful for monitoring ovarian, colorectal, and gastric cancers.

» READ BOOK EXCERPT ONLINE »

Source: Professional Guide to Diseases (Eighth Edition), 2005

Malignant spinal neoplasms: Diagnosis
(Professional Guide to Diseases (Eighth Edition))

❑Spinal and lumbosacral magnetic resonance imaging confirm spinal tumor.

❑ X-rays show distortions of the intervertebral foramina; changes in the vertebrae or collapsed areas in the vertebral body; and localized enlargement of the spinal canal, indicating an adjacent block.

❑ Myelography identifies the level of the lesion by outlining it if the tumor is causing partial obstruction; it shows anatomic relationship to the cord and the dura. If obstruction is complete, the injected dye can't flow past the tumor. (This study is dangerous if cord compression is nearly complete because withdrawal or escape of cerebrospinal fluid (CSF) will allow the tumor to exert greater pressure against the cord.)

❑ Radioisotope bone scan demonstrates metastatic invasion of the vertebrae by showing a characteristic increase in osteoblastic activity.

❑ Computed tomography scan shows cord compression and tumor location.

❑ Frozen section biopsy at surgery identifies the tissue type.

❑ Lumbar puncture may be normal, abnormal, or nonspecific. It may show clear yellow CSF as a result of increased protein levels if the flow is completely blocked. If the flow is partially blocked, protein levels rise, but the fluid is only slightly yellow in proportion to the CSF protein level. Cytology of the CSF may show malignant cells of metastatic carcinoma.

» READ BOOK EXCERPT ONLINE »

Source: Professional Guide to Diseases (Eighth Edition), 2005

Bladder cancer: Diagnosis
(Professional Guide to Diseases (Eighth Edition))

CONFIRMING DIAGNOSIS Only cystoscopy and biopsy confirm bladder cancer. Cystoscopy should be performed when hematuria first appears. When it's performed under anesthesia, a bimanual examination is usually done to determine if the bladder is fixed to the pelvic wall. A thorough history and physical examination may help determine whether the tumor has invaded the prostate or the lymph nodes. (See Comparing staging systems for bladder cancer.)

The following tests can provide essential information about the tumor:

❑Urinalysis can detect blood in the urine and malignant cytology.

❑ Excretory urography can identify a large, early stage tumor or an infiltrating tumor, delineate functional problems in the upper urinary tract, assess hydronephrosis, and detect rigid deformity of the bladder wall.

❑ Retrograde cystography evaluates bladder structure and integrity. Test results help to confirm the diagnosis.

❑ Pelvic arteriography can reveal tumor invasion into the bladder wall.

❑ Computed tomography scan reveals the thickness of the involved bladder wall and detects enlarged retroperitoneal lymph nodes.

❑ Ultrasonography can detect metastasis beyond the bladder and can distinguish a bladder cyst from a tumor.

❑ Excretory urography evaluates the upper urinary tract for tumors or blockage.

» READ BOOK EXCERPT ONLINE »

Source: Professional Guide to Diseases (Eighth Edition), 2005

Cancer of the vulva: Diagnosis
(Professional Guide to Diseases (Eighth Edition))

A Papanicolaou smear that reveals abnormal cells, pruritus, bleeding, or a small vulvar mass strongly suggests vulvar cancer. Firm diagnosis requires histologic examination. Abnormal tissues for biopsy are identified by colposcopic examination to pinpoint vulvar lesions or abnormal skin changes and by staining with toluidine blue dye, which, after rinsing with dilute acetic acid, is retained by diseased tissues.

Other diagnostic measures include complete blood count, X-ray, electrocardiogram, and thorough physical (including pelvic) examination. Occasionally, a computed tomography scan may pinpoint lymph node involvement. (See Staging vulvar cancer.)

» READ BOOK EXCERPT ONLINE »

Source: Professional Guide to Diseases (Eighth Edition), 2005

Cervical cancer: Diagnosis
(Professional Guide to Diseases (Eighth Edition))

A cytologic examination (Papanicolaou [Pap] smear) can detect cervical cancer before clinical evidence appears. (Systems of Pap smear classification may vary from facility to facility.) Abnormal cervical cytology routinely calls for colposcopy, which can detect the presence and extent of preclinical lesions requiring biopsy and histologic examination. Staining may identify areas for biopsy when the smear shows abnormal cells but there's no obvious lesion. Although the tests are nonspecific, they do distinguish between normal and abnormal tissues. Normal tissues absorb the iodine and turn brown; abnormal tissues are devoid of glycogen and won't change color. Additional studies, such as lymphangiography, cystography, and scans, can detect metastasis. (See Staging cervical cancer, page 110.)

» READ BOOK EXCERPT ONLINE »

Source: Professional Guide to Diseases (Eighth Edition), 2005

Colorectal cancer: Diagnosis
(Professional Guide to Diseases (Eighth Edition))

Only a tumor biopsy can verify colorectal cancer, but other tests help detect it:

❑Digital rectal examination can detect almost 15% of colorectal cancers.

❑Fecal occult blood test can detect blood in stools. However, it's commonly negative in patients with colon cancer.

❑ Proctoscopy or sigmoidoscopy can detect up to 66% of colorectal cancers.

❑ Colonoscopy permits visual inspection (and photographs) of the colon up to the ileocecal valve, and gives access for poly-pectomies and biopsies of suspected lesions.

❑ Computed tomography scan helps to detect areas affected by metastasis.

❑ Barium X-ray, using a dual contrast with air, can locate lesions that are undetectable manually or visually. Barium examination should follow endoscopy or excretory urography because the barium sulfate interferes with these tests.

❑Carcinoembryonic antigen, though not specific or sensitive enough for early diagnosis, is helpful in monitoring patients before and after treatment to detect metastasis or recurrence.

» READ BOOK EXCERPT ONLINE »

Source: Professional Guide to Diseases (Eighth Edition), 2005

Esophageal cancer: Diagnosis
(Professional Guide to Diseases (Eighth Edition))

X-rays of the esophagus, with barium swallow and motility studies, reveal structural and filling defects and reduced peristalsis.

CONFIRMING DIAGNOSIS  Endoscopic examination of the esophagus (esophagogastroduodenoscopy), punch and brush biopsies, and exfoliative cytologic tests confirm esophageal tumors. Usually, magnetic resonance imagining of the chest and thoracic computed tomography are helpful in determining disease staging. Positron emission tomography is useful in determining disease staging and whether surgery is possible.

» READ BOOK EXCERPT ONLINE »

Source: Professional Guide to Diseases (Eighth Edition), 2005

Fallopian tube cancer: Diagnosis
(Professional Guide to Diseases (Eighth Edition))

CONFIRMING DIAGNOSIS Unexplained postmenopausal bleeding and an abnormal Papanicolaou smear (suspicious or positive in up to 50% of all cases) suggest fallopian tube cancer, but laparotomy is usually necessary to confirm this diagnosis.

When fallopian tube cancer involves both the ovary and fallopian tube, the primary site is difficult to identify. The preoperative workup includes:

❑ultrasound or plain film of the abdomen to help delineate tumor mass

❑ excretory urography to assess renal function and show urinary tract anomalies and ureteral obstruction

❑ chest X-ray to rule out metastasis

❑ barium enema to rule out intestinal obstruction

❑ computed tomography of the abdomen and pelvis

❑ routine blood studies

❑electrocardiogram.

» READ BOOK EXCERPT ONLINE »

Source: Professional Guide to Diseases (Eighth Edition), 2005

Gallbladder and bile duct cancer: Diagnosis
(Professional Guide to Diseases (Eighth Edition))

No test or procedure, by itself, can diagnose gallbladder cancer. However, the following laboratory tests support the diagnosis when they suggest hepatic dysfunction and extrahepatic biliary obstruction:

❑baseline studies — complete blood count, routine urinalysis, electrolyte studies, enzymes

❑ liver function tests — typically reveal elevated serum bilirubin, urine bile and bilirubin, and urobilinogen levels in more than 50% of patients as well as consistently elevated serum alkaline phosphatase levels

❑ occult blood in stools — linked to the associated anemia

❑ cholecystography — may show calculi or calcification

❑ cholangiography — may locate the site of common duct obstruction

❑ magnetic resonance imaging — detects tumors.

The following tests help compile data that confirm extrahepatic bile duct cancer:

❑ liver function studies — indicate biliary obstruction: elevated levels of bilirubin [5 to 30 mg/dl], alkaline phosphatase, and blood cholesterol as well as prolonged prothrombin time

❑ endoscopic retrograde cannulization of the pancreas — identifies the tumor site and allows access for obtaining a biopsy specimen.

» READ BOOK EXCERPT ONLINE »

Source: Professional Guide to Diseases (Eighth Edition), 2005

Gastric cancer: Diagnosis
(Professional Guide to Diseases (Eighth Edition))

Diagnosis depends primarily on reinvestigations of any persistent or recurring GI changes and complaints. To rule out other conditions producing similar symptoms, diagnostic evaluation must include the testing of blood, stools, and stomach fluid samples.

Diagnosis of gastric cancer generally requires these studies:

❑Barium X-rays of the GI tract with fluoroscopy show changes (tumor or filling defect in the outline of the stomach, loss of flexibility and distensibility, and abnormal gastric mucosa with or without ulceration).

❑ Gastroscopy with fiber-optic endoscopy helps rule out other diffuse gastric mucosal abnormalities by allowing direct visualization and gastroscopic biopsy to evaluate gastric mucosal lesions.

❑ Photography with fiber-optic endoscope provides a permanent record of gastric lesions that can later be used to determine disease progression and effect of treatment.

Certain other studies may rule out specific organ metastasis: computed tomography scans, chest X-rays, liver and bone scans, and liver biopsy. (See Staging gastric cancer, page 84.)

» READ BOOK EXCERPT ONLINE »

Source: Professional Guide to Diseases (Eighth Edition), 2005

Kidney cancer: Diagnosis
(Professional Guide to Diseases (Eighth Edition))

Studies to identify kidney cancer usually include computed tomography scans, excretory urography, retrograde pyelography, ultrasound, cystoscopy (to rule out associated bladder cancer), and nephrotomography or renal angiography to distinguish a kidney cyst from a tumor.

Related tests include liver function studies showing increased levels of alkaline phosphatase, bilirubin, alanine aminotransferase and aspartate aminotransferase, and prolonged prothrombin time. Such results may point to liver metastasis, but if metastasis hasn't occurred, these abnormalities reverse after tumor resection.

Routine laboratory findings of hematuria, anemia (unrelated to blood loss), polycythemia, hypercalcemia, and increased erythrocyte sedimentation rate call for more testing to rule out kidney cancer.

» READ BOOK EXCERPT ONLINE »

Source: Professional Guide to Diseases (Eighth Edition), 2005

Laryngeal cancer: Diagnosis
(Professional Guide to Diseases (Eighth Edition))

Any hoarseness that lasts longer than 2 weeks requires visualization of the larynx by laryngoscopy. (See Staging laryngeal cancer, pages 66 and 67.)

CONFIRMING DIAGNOSIS Firm diagnosis also requires xeroradiography, biopsy, laryngeal tomography, computed tomography scan, or laryngography to define the borders of the lesion and chest X-ray to detect metastasis.

» READ BOOK EXCERPT ONLINE »

Source: Professional Guide to Diseases (Eighth Edition), 2005

Liver cancer: Diagnosis
(Professional Guide to Diseases (Eighth Edition))

CONFIRMING DIAGNOSIS The confirming test for liver cancer is liver biopsy by needle or open biopsy.

Liver cancer is difficult to diagnose in the presence of cirrhosis, but several tests can help identify it:

❑Serum glutamic-oxaloacetic transaminase, serum glutamic-pyruvic transaminase, alkaline phosphatase, lactic dehydrogenase, and bilirubin all show abnormal liver function.

❑ Alpha-fetoprotein rises to a level above 500 mcg/ml.

❑ Chest X-ray may rule out metastasis.

❑ Liver scan may show filling defects.

❑Arteriography may define large tumors.

❑ Electrolyte studies may indicate an increased retention of sodium (resulting in functional renal failure) and hypoglycemia, leukocytosis, hypercalcemia, or hypocholesterolemia.

» READ BOOK EXCERPT ONLINE »

Source: Professional Guide to Diseases (Eighth Edition), 2005

Lung cancer: Diagnosis
(Professional Guide to Diseases (Eighth Edition))

Typical clinical findings may strongly suggest lung cancer, but firm diagnosis requires further evidence.

❑Chest X-ray usually shows an advanced lesion, but it can detect a lesion up to 2 years before symptoms appear. It also indicates tumor size and location.

❑ Sputum cytology, which is 75% reliable, requires a specimen coughed up from the lungs and tracheobronchial tree, not postnasal secretions or saliva.

❑ Computed tomography (CT) scan of the chest may help to delineate the tumor's size and its relationship to surrounding structures.

❑ Bronchoscopy can locate the tumor site. Bronchoscopic washings provide material for cytologic and histologic examination. The flexible fiber-optic bronchoscope increases the test's effectiveness.

❑ Needle biopsy of the lungs uses biplane fluoroscopic visual control to detect peripherally located tumors. This allows firm diagnosis in 80% of patients.

❑ Tissue biopsy of accessible metastatic sites includes supraclavicular and mediastinal node and pleural biopsy. Directed needle biopsy may be performed in conjunction with CT scan.

❑Thoracentesis allows chemical and cytologic examination of pleural fluid.

Additional studies include preoperative mediastinoscopy or mediastinotomy to rule out involvement of mediastinal lymph nodes (which would preclude curative pulmonary resection).

Other tests to detect metastasis include bone scan, bone marrow biopsy (recommended in small cell carcinoma), CT scan of the brain or abdomen, and positron emission tomography.

After histologic confirmation, staging determines the extent of the disease and helps in planning the treatment and predicting the prognosis. (See Staging lung cancer.)

» READ BOOK EXCERPT ONLINE »

Source: Professional Guide to Diseases (Eighth Edition), 2005

Breast cancer: Diagnosis
(Handbook of Diseases)

Diagnostic measures for breast cancer include the following.

Breast self-examination

Although not proven to lower mortality rates, breast self-examination may detect palpable breast lumps, allowing the woman to contact her physician for early evaluation.

Mammography and biopsies

Other diagnostic measures include mammography, a needle biopsy, and a surgical biopsy. Mammography is indicated for any woman whose physical examination might suggest breast cancer. It should be done as a baseline on women ages 35 to 39, every 1 to 2 years for women ages 40 to 49, and annually for women older than age 50, women who have a family history of breast cancer, and women who have had unilateral breast cancer, to check for new disease. However, the value of mammography is questionable for women younger than age 35 (because of the density of the breasts), except those who are strongly suspected of having breast cancer.

False-negative results can occur in as many as 30% of all tests. Consequently, with a suspicious mass, a normal mammogram result should be disregarded, and a fine-needle aspiration or surgical biopsy should be done. Ultrasonography, which can distinguish a fluid-filled cyst from a tumor, can also be used instead of an invasive surgical biopsy.

Other tests

Bone scan, computed tomography scan, measurement of alkaline phosphatase levels, liver function studies, and a liver biopsy can detect distant metastasis. A hormonal receptor assay done on the tumor can determine if the tumor is estrogen- or progesterone-dependent. (This test guides decisions to use therapy that blocks the action of the estrogen hormone that supports tumor growth.)

» READ BOOK EXCERPT ONLINE »

Source: Handbook of Diseases, 2003

Spinal neoplasms: Diagnosis
(Handbook of Diseases)

Spinal computed tomography scan or magnetic resonance imaging shows the location and size of the tumor, or evidence of compression.

Spinal tap shows clear yellow cerebrospinal fluid (CSF) as a result of increased protein levels if the flow is completely blocked. If the flow is partially blocked, protein levels rise, but the fluid is only slightly yellow in proportion to the CSF protein level. A CSF smear may show malignant cells of metastatic carcinoma.

X-rays show distortions of the intervertebral foramina, changes in the vertebrae, collapsed areas in the vertebral body, and localized enlargement of the spinal canal, indicating an adjacent block.

Myelography identifies the level of the lesion by outlining it if the tumor is causing partial obstruction; it shows the anatomic relationship of the tumor to the cord and the dura. If the obstruction is complete, the injected dye can’t flow past the tumor.

Note: This study is dangerous if cord compression is nearly complete because withdrawal or escape of CSF will actually allow the tumor to exert greater pressure against the cord.

Radioisotope bone scan demonstrates metastatic invasion of the vertebrae by showing a characteristic increase in osteoblastic activity.

Frozen section biopsy at surgery identifies the tissue type.

» READ BOOK EXCERPT ONLINE »

Source: Handbook of Diseases, 2003

Bladder cancer: Diagnosis
(Handbook of Diseases)

Only cystoscopy and a biopsy can confirm bladder cancer. Cystoscopy should be performed when hematuria first appears. When it’s performed under anesthesia, a bimanual examination is usually done to determine if the bladder is fixed to the pelvic wall. A thorough history and physical examination may help determine whether the tumor has invaded the prostate or the lymph nodes.

The following tests can provide essential information about the tumor:

Urinalysis can detect blood in the urine and malignant cytology.

Excretory urography can identify a large, early-stage tumor or an infiltrating tumor, delineate functional problems in the upper urinary tract, assess hydronephrosis, and detect rigid deformity of the bladder wall.

Retrograde cystography evaluates bladder structure and integrity. Test results help to confirm the diagnosis.

Pelvic arteriography can reveal tumor invasion into the bladder wall.

Computed tomography scan reveals the thickness of the involved bladder wall and detects enlarged retroperitoneal lymph nodes.

Ultrasonography can detect metastasis beyond the bladder and can distinguish a bladder cyst from a tumor.

» READ BOOK EXCERPT ONLINE »

Source: Handbook of Diseases, 2003

Cervical cancer: Diagnosis
(Handbook of Diseases)

A cytologic examination (Papanicolaou [Pap] test) can be used to detect cervical cancer before symptoms appear. Abnormal cervical cytology generally calls for colposcopy, which can detect the presence and extent of preclinical lesions requiring a biopsy and histologic examination.

Staining with Lugol’s solution (strong iodine) or Schiller’s solution (iodine, potassium iodide, and purified water) may identify areas for a biopsy when the smear shows abnormal cells but there is no obvious lesion. Although the tests are nonspecific and have a high rate of false-positives, they do distinguish between normal and abnormal tissues: Normal tissues absorb the iodine and turn brown; abnormal tissues are devoid of glycogen and don’t change color.

Additional studies — such as cystography, magnetic resonance imaging, computed tomography and bone scans — can be used to detect metastasis.

» READ BOOK EXCERPT ONLINE »

Source: Handbook of Diseases, 2003

Colorectal cancer: Diagnosis
(Handbook of Diseases)

Only a tumor biopsy can verify colorectal cancer, but the following tests help detect it:

Digital examination can help detect almost 15% of colorectal cancers.

Hemoccult test (guaiac) may show blood in the stool.

Proctoscopy or sigmoidoscopy can help detect up to 66% of colorectal cancers.

Colonoscopy permits visual inspection (and photographs) of the colon up to the ileocecal valve and gives access for polypectomies and biopsies of suspected lesions.

Computed tomography scan helps detect areas affected by metastasis.

Barium X-ray, using a dual contrast with air, can locate lesions that are undetectable manually or visually. Barium examination should follow endoscopy or excretory urography because the barium sulfate interferes with these tests.

Carcinoembryonic antigen, although not specific or sensitive enough for an early diagnosis, is helpful in monitoring patients before and after treatment to detect metastasis or recurrence.

» READ BOOK EXCERPT ONLINE »

Source: Handbook of Diseases, 2003

Esophageal cancer: Diagnosis
(Handbook of Diseases)

X-rays of the esophagus, with barium swallow and motility studies, reveal structural and filling defects and reduced peristalsis. Endoscopic examination of the esophagus, punch and brush biopsies, and an exfoliative cytologic tests confirm esophageal tumors.

» READ BOOK EXCERPT ONLINE »

Source: Handbook of Diseases, 2003

Gallbladder and bile duct cancers: Diagnosis
(Handbook of Diseases)

No test or procedure is in itself diagnostic of gallbladder cancer. However, the following laboratory tests support this diagnosis when they suggest hepatic dysfunction and extrahepatic biliary obstruction:

baseline studies (complete blood count, routine urinalysis, electrolyte studies, enzymes)

liver function tests (typically reveal elevated serum bilirubin, urine bile and bilirubin, and urobilinogen levels in more than 50% of patients as well as consistently elevated serum alkaline phosphatase levels)

occult blood in stools (linked to the associated anemia)

cholecystography (may show stones or calcification)

cholangiography (may locate the site of common duct obstruction)

magnetic resonance imaging (detects tumors).

The following tests help compile data that confirm extrahepatic bile duct cancer:

liver function tests (indicate biliary obstruction: elevated levels of bilirubin [5 to 30 mg/dl], alkaline phosphatase, and blood cholesterol as well as prolonged prothrombin time)

endoscopic retrograde pancreatography (identifies the tumor site and allows access for obtaining a biopsy specimen).

» READ BOOK EXCERPT ONLINE »

Source: Handbook of Diseases, 2003

Gastric cancer: Diagnosis
(Handbook of Diseases)

Diagnosis depends primarily on reinvestigations of persistent or recurring GI changes and complaints. To rule out other conditions that produce similar symptoms, a diagnostic evaluation must include the testing of blood, stools, and stomach fluid specimens.

Gastric cancer commonly requires the following studies for diagnosis:

Barium X-rays of the GI tract, with fluoroscopy, show changes (a tumor or filling defect in the outline of the stomach, loss of flexibility and distensibility, and abnormal gastric mucosa with or without ulceration).

Gastroscopy with fiber-optic endoscopy helps rule out other diffuse gastric mucosal abnormalities by allowing direct visualization and gastroscopic biopsy to evaluate gastric mucosal lesions.

Endoscopy for biopsy and cytologic washings and photography with fiber-optic endoscopy provide a permanent record of gastric lesions that can later be used to determine the progress of the disease and the effect of treatment.

The following studies may rule out metastasis to specific organs: computed tomography scans, chest X-rays, liver and bone scans, and a liver biopsy.

» READ BOOK EXCERPT ONLINE »

Source: Handbook of Diseases, 2003

Kidney cancer: Diagnosis
(Handbook of Diseases)

Studies to identify kidney cancer usually include computed tomography scans, excretory urography and retrograde pyelography, ultrasound, cystoscopy (to rule out associated bladder cancer), and nephrotomography or renal angiography to distinguish a kidney cyst from a tumor.

Related tests include liver function studies showing increased levels of alkaline phosphatase, bilirubin, alanine aminotransferase, and aspartate aminotransferase as well as prolonged prothrombin time. Such results may point to liver metastasis, but if metastasis hasn’t occurred, these abnormalities reverse after the tumor has been resected.

Routine laboratory findings of hematuria, anemia (unrelated to blood loss), polycythemia, hypercalcemia, and increased erythrocyte sedimentation rate call for more testing to rule out kidney cancer. A bone scan should also be performed to rule out skeletal metastasis.

» READ BOOK EXCERPT ONLINE »

Source: Handbook of Diseases, 2003

Laryngeal cancer: Diagnosis
(Handbook of Diseases)

Any hoarseness that lasts longer than 2 weeks requires visualization of the larynx by laryngoscopy.

A firm diagnosis also requires xeroradiography, a biopsy, laryngeal tomography, computed tomography scan, or laryngography to define the borders of the lesion, and a chest X-ray to detect metastasis.

» READ BOOK EXCERPT ONLINE »

Source: Handbook of Diseases, 2003

Liver cancer: Diagnosis
(Handbook of Diseases)

The confirming test for liver cancer is a needle or open biopsy of the liver. Liver cancer is difficult to diagnose in the presence of cirrhosis, but several tests can help identify it:

Liver function studies (aspartate aminotransferase, alanine aminotransferase, alkaline phosphatase, lactate dehydrogenase, and bilirubin) show abnormal liver function.

Alpha-fetoprotein level increases above 500 µg/ml.

Chest X-ray may rule out metastasis.

Liver scan may show filling defects.

Arteriography may define large tumors.

Electrolyte studies may indicate increased sodium retention (resulting in functional renal failure) and hypoglycemia, leukocytosis, hypercalcemia, or hypocholesterolemia.

» READ BOOK EXCERPT ONLINE »

Source: Handbook of Diseases, 2003

Lung cancer: Diagnosis
(Handbook of Diseases)

Typical signs and symptoms may strongly suggest lung cancer, but a firm diagnosis requires further evidence, including the following:

Chest X-ray usually shows an advanced lesion, but it can detect a lesion up to 2 years before symptoms appear. It also indicates tumor size and location.

Sputum cytology is marginally helpful in obtaining a diagnosis. It requires a specimen coughed up from the lungs and tracheobronchial tree, not postnasal secretions or saliva.

Computed tomography (CT) scan of the chest may help to delineate the tumor’s size and its relationship to surrounding structures.

Bronchoscopy can locate the tumor site. Bronchoscopic washings provide material for cytologic and histologic examination. The flexible fiber-optic bronchoscope increases the test’s effectiveness.

❑ A needle biopsy of the lungs uses biplane fluoroscopic visual control or CT guidance to detect peripherally located tumors. This allows a firm diagnosis in 80% of patients.

Tissue biopsy of accessible metastatic sites includes supraclavicular and mediastinal node and pleural biopsies.

Thoracentesis allows chemical and cytologic examination of pleural fluid.

Additional studies include preoperative mediastinoscopy or mediastinotomy to rule out involvement of mediastinal lymph nodes (which would preclude curative pulmonary resection).

Other tests to detect metastasis include a bone scan, positron emission tomography scan, bone marrow biopsy (recommended in small cell carcinoma), and a CT scan of the brain or abdomen.

After histologic confirmation, staging determines the extent of the disease and helps in planning treatment and predicting the prognosis. (See Staging lung cancer.)

» READ BOOK EXCERPT ONLINE »

Source: Handbook of Diseases, 2003

Ovarian cancer: Diagnosis
(Handbook of Diseases)

With ovarian cancer, diagnosis requires clinical evaluation, a complete patient history, surgical exploration, and histologic studies. Preoperative evaluation includes a complete physical examination, including pelvic examination with Papanicolaou smear (not clinically useful for ovarian cancer but helpful in diagnosing cervical dysplasia, cervical cancer, and some endometrial cancers) and the following special tests:

abdominal ultrasonography, computed tomography scan, or magnetic resonance imaging (may delineate tumor size)

complete blood count and blood chemistries

chest X-ray for distant metastasis and pleural effusions

barium enema (especially in patients with GI symptoms) to reveal obstruction and size of tumor

mammography to rule out primary breast cancer

liver function studies or a liver scan in patients with ascites

laboratory tumor marker studies, such as CA-125, carcinoembryonic antigen, and human chorionic gonadotropin (the last two are mainly for suspected germ cell tumors).

Despite extensive testing, accurate diagnosis and staging are impossible without exploratory laparotomy, including lymph node evaluation and tumor resection.

» READ BOOK EXCERPT ONLINE »

Source: Handbook of Diseases, 2003

Pancreatic cancer: Diagnosis
(Handbook of Diseases)

Definitive diagnosis requires a laparotomy with a biopsy. Other tests used to detect pancreatic cancer include:

ultrasound — can identify a mass but not its histology

computed tomography scan — similar to ultrasound but shows greater detail

angiography — shows vascular supply of tumor

endoscopic retrograde cholangiopancreatography — allows visualization, instillation of contrast medium, and specimen biopsy

magnetic resonance imaging — shows tumor size and location in great detail.

Laboratory tests that can help support this diagnosis include serum bilirubin level (increased), serum amylase and serum lipase levels (sometimes elevated), prothrombin time (prolonged), and aspartate aminotransferase and alanine aminotransferase levels (elevations indicate necrosis of liver cells).

Additional pertinent studies include  alkaline phosphatase level (marked elevation occurs with biliary obstruction), plasma insulin immunoassay (shows measurable serum insulin in the presence of islet cell tumors), hemoglobin level and hematocrit (may show mild anemia), fasting blood glucose level (may indicate hypoglycemia or hyperglycemia), and stool analysis (occult blood may signal ulceration in the GI tract or ampulla of Vater).

» READ BOOK EXCERPT ONLINE »

Source: Handbook of Diseases, 2003

Prostatic cancer: Diagnosis
(Handbook of Diseases)

A digital rectal examination that reveals a small, hard nodule may help diagnose prostatic cancer. The American Cancer Society advises a yearly digital examination for men older than age 40, a yearly blood test to detect prostate-specific antigen (PSA) in men older than age 50, and ultrasonography if abnormal results are found.

Biopsy confirms the diagnosis. PSA is produced by the normal neoplastic ductal epithelium of the prostate and secreted into the lumen; its concentration in the blood is proportional to the total prostate mass. PSA levels will be elevated in all patients with prostatic cancer, and serum acid phosphatase levels will be elevated in two-thirds of men with metastatic prostatic cancer. Therapy aims to return the serum acid phosphatase level to normal; a subsequent rise points to recurrence. Magnetic resonance imaging, computed tomography scan, and excretory urography may also aid the diagnosis.

CLINICAL TIP: Elevated alkaline phosphatase levels and a positive bone scan point to bone metastasis.

» READ BOOK EXCERPT ONLINE »

Source: Handbook of Diseases, 2003


 » Next page: Signs of Cancer

Rate This Website

What do you think about the features of this website? Take our user survey and have your say:

Website User Survey

Medical Tools & Articles:

Next articles:

Tools & Services:

Medical Articles:

Forums & Message Boards

 
HONcode We subscribe to the HONcode principles

By using this site you agree to our Terms of Use. Information provided on this site is for informational purposes only; it is not intended as a substitute for advice from your own medical team. The information on this site is not to be used for diagnosing or treating any health concerns you may have - please contact your physician or health care professional for all your medical needs. Please see our Terms of Use.

Home | Symptoms | Diseases | Diagnosis | Videos | Tools | Forum | About Us | Terms of Use | Privacy Policy | Site Map | Advertise